Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
|
|
ROCKWELL MEDICAL, INC. (RMTI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/31/2021 |
GN
| Rockwell Medical, Inc. Provides Fourth Quarter and Full Year 2020 Financial and Operational Update |
| 02/01/2021 |
GN
| Rockwell Medical Announces Submission of Triferic® New Drug Application in South Korea by Partner, Jeil Pharmaceutical Co., Ltd. |
| 01/13/2021 |
GN
| Rockwell Medical Announces Dosing of First Patient in Pivotal Triferic® Phase 3 Trial by Partner, Wanbang Biopharmaceuticals, in China |
| 01/05/2021 |
GN
| Rockwell Medical, Inc. to Present at H.C. Wainwright BioConnect 2021 Conference |
| 10/27/2020 |
GN
| Rockwell Medical to Report Third Quarter 2020 Financial and Operating Results on November 9, 2020 |
| 09/24/2020 |
GN
| Rockwell Medical Announces Growth Plan and New Therapeutic Opportunities for Its Ferric Pyrophosphate Citrate (FPC) Platform |
| 09/23/2020 |
GN
| Rockwell Medical Announces $35.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules |
| 09/15/2020 |
GN
| Rockwell Medical Announces Appointment of Russell L. Skibsted as Executive Vice President, Chief Financial Officer and Chief Business Officer |
| 06/10/2020 |
GN
| Rockwell Medical, Inc. Appoints Dr. Allen R. Nissenson to Board of Directors |
| 05/26/2020 |
GN
| Rockwell Medical, Inc. Files New Drug Submission with Health Canada for Marketing Approval of Triferic® AVNU™ |
| 03/31/2020 |
GN
| Rockwell Medical, Inc. Appoints Pharmaceutical Industry Leader Robert S. Radie to Board of Directors |
| 03/27/2020 |
GN
| Rockwell Medical, Inc. Receives FDA Approval for Triferic® AVNU (Ferric Pyrophosphate Citrate), Intravenous Formulation of Triferic for Replacement of Iron and Maintenance of Hemoglobin in Hemodialysis Patients |
| 03/20/2020 |
GN
| Rockwell Medical, Inc. Confirms Medical Resource Acquisition Group's Director Nominations Are Invalid |
| 03/18/2020 |
GN
| Medical Resource Acquisition Group, LLC is Focused on Replacing Rockwell Medical Directors to Balance the Board, Improve Governance and Bring Much-Needed Transparency to RMTI Shareholders |
| 03/17/2020 |
GN
| Rockwell Medical, Inc. Announces $35 Million Debt Financing Agreement with Innovatus Capital Partners, LLC |
| 03/12/2020 |
GN
| Medical Resource Acquisition Group LLC Refutes the Position Taken by Rockwell Medical Inc.'s Directors That They Did Not File Their Slate of Directors Correctly or in a Timely Manner |
| 03/10/2020 |
GN
| Rockwell Medical Acknowledges Receipt of Communications from Medical Resource Acquisition Group |
| 03/09/2020 |
GN
| Rockwell Medical, Inc. Offered $15 Million by Medical Resource Acquisition Group, LLC |
| 03/04/2020 |
GN
| Rockwell Medical, Inc. to Discuss Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020 |
| 01/14/2020 |
GN
| Rockwell Medical, Inc. Enters into Exclusive License and Supply Agreements with Sun Pharma for the Rights to Commercialize Triferic® in India |
| 01/09/2020 |
GN
| Rockwell Medical, Inc. Appoints Russell H. Ellison, MD, MSc, to Board of Directors |
| 01/08/2020 |
GN
| Rockwell Medical, Inc. to Present at Biotech Showcase 2020 |
| 11/20/2019 |
GN
| Rockwell Medical, Inc. Expands Medical Capabilities |
| 11/11/2019 |
GN
| Rockwell Medical, Inc. Reports Third Quarter 2019 Financial Results |
| 11/07/2019 |
GN
| Rockwell Medical, Inc. to Sponsor Triferic® Exhibitor Spotlight Presentation at American Society of Nephrology Conference |
| 11/04/2019 |
GN
| Rockwell Medical, Inc. to Discuss Third Quarter 2019 Financial Results on November 11, 2019 |
| 10/31/2019 |
GN
| Rockwell Medical, Inc. Appoints John P. McLaughlin Chairman of the Board of Directors |
| 10/24/2019 |
GN
| Rockwell Medical, Inc. Provides Business Update |
| 09/24/2019 |
GN
| Rockwell Medical, Inc. to Present at 2019 Cantor Global Healthcare Conference |
| 09/05/2019 |
GN
| Rockwell Medical, Inc. Appoints Industry Veteran John P. McLaughlin to Board of Directors |
| 08/28/2019 |
GN
| Rockwell Medical, Inc. to Present at Upcoming September Conferences |
| 06/18/2019 |
GN
| Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Rockwell Medical, Amneal Pharmaceuticals, Kraft Heinz, and Intuit and Encourages Investors to Contact the Firm |
| 06/18/2019 |
GN
| Rockwell Medical Announces Pricing of $17.5 Million Public Offering of Common Stock |
| 06/17/2019 |
GN
| Rockwell Medical Announces Proposed Public Offering of Common Stock |
|
|
|